Koers Global Cord Blood Corp Nyse
Aandelen
KYG211071009
Gezondheidszorgvoorzieningen & -diensten
Omzet 2021 | 1,16 mld. 161 mln. 149 mln. | Omzet 2022 | 1,24 mld. 172 mln. 160 mln. | Marktkapitalisatie | 2,97 mld. 411 mln. 382 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 508 mln. 70,4 mln. 65,38 mln. | Nettowinst (verlies) 2022 | 501 mln. 69,43 mln. 64,48 mln. | EV/omzet 2021 | -2,13 x |
Nettoliquiditeiten 2021 | 6,07 mld. 842 mln. 782 mln. | Nettoliquiditeiten 2022 | 6,66 mld. 923 mln. 857 mln. | EV/omzet 2022 | -2,97 x |
K/w-verhouding 2021 |
7,1
x | K/w-verhouding 2022 |
5,93
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 38,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 01-01-09 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 01-01-09 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 01-11-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 01-01-09 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 01-01-09 |
Director/Board Member | 56 | 01-01-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,55% | 81,21 mld. | |
-29,12% | 70,26 mld. | |
+11,76% | 29,62 mld. | |
-11,55% | 16,95 mld. | |
-0,71% | 16,91 mld. | |
-1,62% | 15,07 mld. | |
+4,35% | 12,52 mld. | |
-30,88% | 11,92 mld. | |
-5,39% | 12,1 mld. |